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Endovascular grafts are being scrutinized as pos-
sible alternatives to conventional grafts for the treat-
ment of abdominal aortic aneurysms.1-14
Incomplete exclusion or endoleaks are among the
most common complications of endovascular
aneurysm repair and result in ongoing perfusion of
the aneurysm sac. Endoleaks usually indicate proce-
dural failure and when untreated may cause
aneurysm rupture. To better understand the uncer-
tain pathogenesis, fate, and significance of
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endoleaks, we reviewed our experience with
endovascular abdominal aortic aneurysm repair. We
identified graft-, patient-, and technique-related fac-
tors associated with endoleaks and developed
anatomic, chronologic, and physiologic classification
systems to facilitate their reporting and analysis.
MATERIALS AND METHODS
Patients. All patients who had abdominal aortic
aneurysms larger than 5 cm diagnosed between
November 1992 and May 1997 were eligible for
endovascular repair. High-risk patients with severe
cardiopulmonary disease, a hostile abdomen, or
other major coexisting medical problems were
offered treatment with Parodi-type balloon-expand-
able endovascular grafts. Good-risk patients were
asked to participate in the phase I North American
trial of the Endovascular Technologies (EVT)
endovascular graft7 (Menlo Park, Calif.). Patients
who did not meet the inclusion criteria for these
studies or who refused to participate were treated
with standard open surgery or were observed.
Endovascular procedures. A detailed descrip-
tion of the endovascular grafts used in this study has
been reported elsewhere.5 Briefly, the EVT grafts
were constructed from self-expanding hooked “Z”
stents and woven Dacron prosthetic tubes. The
Parodi-type devices were originally constructed from
thin-walled knitted Dacron grafts (Barone, Inc.,
Buenos Aires, Argentina) and more recently from 8
mm polytetrafluoroethylene grafts (Impra, Inc.,
Tempe, Ariz.) predilated proximally to 30 mm.
These grafts were sutured to Palmaz balloon-
expandable aortic stents with four sutures (P5014
Johnson and Johnson Interventional Systems,
Warren, N.J.) so that one-half the length of each
stent was overlapped by graft material.
In the first phase of our study, high-risk patients
who had proximal and distal aneurysm neck lengths
1.5 cm or greater were treated with endovascular
aortoaortic tube grafts. Patients who had distal neck
lengths less than 1.5 cm or common iliac artery
involvement were treated with aortoiliac endovascu-
lar grafts and femorofemoral bypass grafts with con-
tralateral common iliac artery occluder devices.
These grafts were anchored proximally by balloon-
expandable stents placed beneath the renal arteries.
The grafts were anchored distally in the aorta, com-
mon, or external iliac artery with a second stent.
Good-risk patients treated under the EVT protocol
also had their grafts anchored by two stents; one
deployed beneath the renal arteries and one proxi-
mal to the aortic bifurcation.
In phase II, all of the patients were treated with
tapered aortofemoral endovascular grafts and femo-
rofemoral bypass grafts with occlusion of the oppo-
site common iliac artery. The proximal stent of these
grafts was deployed near or across the orifice of one
or both renal arteries so that the proximal end of the
prosthetic graft was affixed just inferior to the orifice
of the lowest renal artery. The graft ended distally in
the common femoral artery with a sutured endolu-
minal anastomosis. At the time of surgery, these
patients had already undergone coil embolization of
the intended ipsilateral hypogastric artery on com-
pletion of the preoperative angiogram (Table I).
Devices were inserted under Institutional Review
Board supervision and in phase II under an investi-
gator-sponsored investigational device exemption
(IDE) from the Food and Drug Administration.
Patient follow-up. Completion angiograms
were obtained in the operating room to discover
endoleaks. Spiral computed tomographic (CT) scans
were performed within the first postoperative week
unless the patient had renal insufficiency or another
contraindication to the early readministration of
intravenous contrast material. Color flow duplex
studies were also obtained within a week after graft
insertion. Follow-up CT scans and duplex studies
were obtained at 3 months, 6 months, and yearly
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Table I. Endovascular graft and technique-related differences between phase I and phase II
Phase I Phase II
Graft type Aortoaortic (tube) EVT (tube) Aortoiliac, femorofemoral Aortofemoral, femorofemoral
Graft material Knitted Dacron Woven Dacron PTFE PTFE
No. of patients 7 4 8 28
Proximal stent 
placement Infrarenal aorta Infrarenal aorta Infrarenal aorta Juxtarenal aorta
Distal graft placement Distal aorta Distal aorta Iliac artery Femoral artery
Method of distal Stent Stent Stent Sutured endoluminal 
graft fixation anastomosis
Preoperative hypogastric Not applicable Not applicable No Yes
artery coil embolization
PTFE, Polytetrafluoroethylene.
thereafter. The presence of perigraft, intrasaccular
contrast material on a CT scan or angiogram or flow
in this location on a duplex study indicated the pres-
ence of an endoleak.
Data collection and analysis. Aneurysm charac-
teristics, including maximum diameter, neck length,
and degree of calcification; presence of patent side
branches (e.g., lumbar, hypogastric, or inferior
mesenteric arteries); and association with iliac
aneurysms or occlusive disease were assessed before
operation with spiral CT scans and arteriography.
CT scan images were acquired using 3-mm-thick
transverse cuts obtained at 6 mm intervals. The
degree of aneurysm neck calcification was recorded
as the number of aortic quadrants (0 to 4) that con-
tained calcification on the first transverse noncon-
trast CT image below the lowest renal artery.
Patients were divided into two groups on the basis
of the degree of neck calcification: those with severe
(four quadrant) calcification and those with less-
extensive involvement. Aneurysm neck length was
the distance measured on CT scan between the most
inferior renal artery and the start of the aneurysm.
Extent of aneurysm involvement was graded accord-
ing to previously described reporting standards for
infrarenal endovascular abdominal aortic aneurysm
repair.15 Data were analyzed on a personal comput-
er using Microsoft Excel v. 5.0 and Fisher’s exact
test.
RESULTS
Forty-six patients underwent 47 endovascular
procedures to treat their aneurysms. The average
age of the patients was 77.6 years, 42 were men, and
the mean preoperative aneurysm sac diameter was
6.4 cm. Nineteen patients (41%) were treated in
phase I of the trial. These patients received Parodi-
type aortoaortic (7) or aortoiliac, femorofemoral
grafts (8), or an EVT graft (4). In phase II all 28
patients received aortofemoral, femorofemoral
grafts. Patent aneurysm side branches were observed
in 19 patients. Eleven patients (24%) had iliac occlu-
sive disease, 16 (35%) had iliac aneurysmal disease,
28 (61%) had a proximal neck length 2.0 cm or less,
and seven (15%) had severe neck calcification. The
percentage of patients with complex (grade IV)
aneurysms was similar in the first and second phases
of the study (16% and 14%, respectively).
A total of 17 aneurysm repairs (36%) were com-
plicated by endoleaks. These were discovered in 11
patients treated in phase I of the study (58%) and in
only six patients treated in phase II (21%). Of the
phase I patients, endoleaks complicated four aor-
toaortic grafts (57%), four aortoiliac, femorofemoral
grafts (50%), and three EVT grafts (75%). All of the
patients who had grade IV aneurysms treated in
phase I of the study had endoleaks, compared with
only 50% of those treated in phase II.
Aortic characteristics and endoleak incidence.
Aneurysms with neck lengths 2 cm or less experi-
enced a significantly higher rate of endoleaks than
those that had longer necks (50% vs 16%; p < 0.05).
The rate of endoleaks was also increased, but not in
a statistically significant fashion in patients with
patent aneurysm side branches and severe aneurysm
neck calcification compared with that in patients
who did not have these features (47% vs 29%, p =
0.10 and 57% vs 33%, p = 0.15, respectively).
Patients with iliac occlusive disease had fewer (but
not significantly fewer) endoleaks than those with-
out occlusive disease (42% vs 18%; p = 0.11), and
aneurysm sac diameter did not significantly influ-
ence the rate of endoleaks.
Endoleak classification. A three-part classifica-
tion system was developed to describe aortic
aneurysm endoleaks. An anatomic classification
describes the site of origin and outflow status of the
endoleak. Endoleaks can originate from the proxi-
mal, distal, or midgraft segment of an endovascular
device or from the contralateral iliac artery occluder
(Fig. 1). Midgraft endoleaks can begin at an arterial
side branch, such as the inferior mesenteric,
hypogastric, lumbar, or accessory renal artery, at a
graft defect, or between components of a modular
device. Outflow is present when an endoleak exits
the aneurysm sac (Fig. 2). Outflow is absent when
an endoleak terminates as a “pseudoaneurysm”
within the aneurysm sac (Table II).
A chronologic classification stratifies endoleaks
according to their time of onset and fate. Endoleaks
are immediate when they are discovered on the first
postoperative imaging study; delayed when they are
not present on the initial study but are visualized on
a subsequent study; or recurrent when they are ini-
tially seen but seal, only to “reopen” during follow-
up (Fig. 3). Fate describes the history of an
endoleak: an endoleak can be persistent throughout
the follow-up period; seal spontaneously; or seal
with additional intervention (Table III).
A physiologic classification describes endoleaks
according to their source of inflow. Endoleaks can
originate directly from the aorta or indirectly via col-
lateral channels (Table IV).
Management of endoleaks. An attempt was
made to treat all endoleaks unless the patient’s med-
ical condition or the technical feasibility of a sec-
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ondary procedure precluded treatment. Three
patients underwent additional procedures to seal
their endoleaks. One patient had undergone suc-
cessful implantation of an EVT tube graft that devel-
oped a delayed endoleak as a result of a hook frac-
ture within its attachment system. When the
aneurysm became pulsatile, the patient’s endoleak
was sealed by an aortofemoral, femorofemoral graft
deployed within the lumen of the EVT graft (Fig.
4). A second patient experienced an endoleak 5
months after placement of an aortoaortic tube graft.
A postoperative CT scan demonstrated perigraft,
intrasaccular contrast material that we thought was
caused by implantation of the distal aspect of the
graft within aortic thrombus. This patient under-
went an open sutured extension to the aortic bifur-
cation to repair the endoleak. The final patient experi-
enced an immediate occluder device endoleak after
treatment with an aortofemoral, femorofemoral graft.
He had multiple coils angiographically placed within
the occluder device on the first postoperative day,
which resulted in closure of the endoleak (Fig. 5).
DISCUSSION
The successful treatment of an aneurysm depends
on its complete exclusion from the arterial circulation.
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Fig. 1.  An 88-year-old man underwent elective repair of an 8 cm abdominal aortic aneurysm with an aor-
toiliac, femorofemoral graft. A, Postoperative CT scan demonstrates large endoleak (el) adjacent to
endovascular graft (g). B, Two-dimensional CT reconstruction shows that endoleak (el) originates at prox-
imal portion of endovascular graft (g) and ends within distal aneurysm sac (s).
Incomplete fixation of an endovascular graft may
result in persistent flow within the aneurysm sac.
This flow, which may also arise from patent inferior
mesenteric, lumbar, hypogastric, or accessory renal
arteries, is called an endoleak.16 Endoleaks have
been reported to complicate between 8% and 44% of
all endovascular abdominal aortic aneurysm repairs.
To date, at least seven patients who had endoleaks
after these procedures have had aneurysm rup-
ture.3,12,17,18 These cases, as well as experimental
studies and data on patients whose aneurysms were
treated with nonresective procedures, suggest that
endoleaks can cause aneurysm rupture.
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Fig. 2. Patient with endoleak after placement of EVT
tube graft. A, Transverse CT scan image shows that
endoleak (el) takes on C-shaped configuration within
aneurysm sac. Endovascular graft (g) is also shown. B,
Three-dimensional reconstruction shows zig-zag config-
uration of proximal stent (s) and endoleak (el) originating
adjacent to stent. Endoleak travels around aneurysm sac
and has outflow through a patent lumbar vessel.
Table II. Anatomic classification of endoleaks
Endoleak feature No. (%)
Site
Proximal end of graft 10 (59)
Distal end of graft 3 (17)
Midgraft 2 (12)
Arterial side branch* 2 (12)
Graft defect 0 (0)
Between modular device components 0 (0)
Occluder device 2 (12)
Outflow
Present† 5 (29)
Absent 12 (71)
*One of the side branch endoleaks originated at the hypogastric
artery and the other from a lumbar artery.
†Of those endoleaks with outflow, the vessel involved was a lum-
bar artery in three patients and a hypogastric artery in two.
Table III. Chronologic classification of endoleaks
Endoleak feature No. (%)
Time of onset
Immediate 12 (71)
Delayed* 4 (24)
Recurrent† 1 (5)
Fate
Persistent‡ 12 (71)
Sealed 5 (29)
Spontaneously§ 2 (12)
With intervention 3 (17)
*One medically ill patient with a delayed endoleak died of a
ruptured aneurysm 18 months after his repair.
†Patient had an immediate endoleak that sealed spontaneously
and then recurred.
‡Of the 12 persistent endoleaks, four had evidence of outflow
and eight did not.
§ One endoleak that sealed spontaneously did so 1 month after
surgery and was a proximal endoleak without outflow. The
other was a midgraft endoleak with outflow that sealed 2
months after surgery.
An association between endoleaks and rupture
has been demonstrated in canine aneurysm mod-
els. Criado et al.19 created aneurysms with full-
thickness jejunal patches, which, in contrast to
prosthetic patches, were susceptible to rupture.
After endovascular graft treatment of these
aneurysms, the aorta-aneurysm sac pressure differ-
ential was measured. In dogs without endoleaks,
the pressure differential was high and there were
no reports of aneurysm rupture. In dogs with
endoleaks, there was no significant pressure differ-
ential and all of the aneurysms ruptured within 5
days of surgery.
Aneurysm sac pressure was also measured in a
canine endoleak model developed in our laboratory
using polytetrafluoroethylene interposition
aneurysms.20 When these aneurysms were success-
fully excluded by an endovascular graft, a large
aorta-aneurysm sac pressure gradient was observed.
When an endovascular graft containing a fenestra-
tion (simulating an endoleak) was implanted, pres-
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Fig. 3. Patient was treated with tube graft and had imme-
diate distal endoleak that sealed spontaneously and then
recurred. A, Postoperative CT scan shows contrast mater-
ial within graft (g) and endoleak (el). B, Subsequent CT
scan obtained 2 months later reveals flow only within graft
(g) and no evidence of endoleak. C, One year later, sur-
veillance CT scan demonstrates graft (g) and recurrent
endoleak (el). D, Angiogram reveals that proximal stent
(a) remains incorporated within infrarenal aorta. Distal
stent (b) that was inserted at aortic bifurcation (c) has
become disincorporated and now lies within aneurysm sac.
Contrast material from this distal endoleak fills aneurysm
sac (el).
sure remained elevated in the aneurysm sac and min-
imal aorta-aneurysm pressure gradients were mea-
sured.21
Retroperitoneal exclusion for the treatment of
abdominal aortic aneurysms is an alternative to
transabdominal endoaneurysmorrhaphy. Resnikoff
et al.22 reported on the retroperitoneal exclusion
of 831 aneurysms and found that 17 patients who
underwent this procedure had residual flow with-
in their aneurysm sacs. Of these, 14 patients
underwent a second operation to treat abdominal
or back pain related to the aneurysm or aneurysm
rupture. The residual flow originated from iliac,
lumbar, or inferior mesenteric arteries. Other cases
of aneurysm rupture after nonresective repairs
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Table IV. Physiologic classification of endoleaks
Endoleak feature No. (%)
Inflow
Aortic 15 (88)
Proximal end of graft 10 (59)
Distal end of graft 3 (17)
Graft defect 0 (0)
Occluder device* 2 (12)
Collateral† 2 (12)
Arterial side branch (hypogastric, lumbar,
accessory renal, or inferior mesenteric artery)
*By definition, occluder device endoleaks are considered in this
group even though reperfusion of the aneurysm sac occurs in an
indirect fashion through the femorofemoral bypass graft.
†These originated from a hypogastric and a lumbar artery in
patients who were treated during phase II of the study.
Fig. 4. Endovascular repair of endoleak caused by structural failure of previously inserted endovascular
graft. Patient was treated with EVT tube graft and experienced delayed distal endoleak 1.5 years after oper-
ation when metallic hooks on distal attachment device fractured. A, Arteriogram demonstrates large
endoleak (el) adjacent to broken distal stent (b). B, Endoleak (el) can be seen on follow-up CT scan next
to endovascular graft (g). C, Patient underwent a reparative procedure in which a second endovascular
graft was deployed within the first graft. Follow-up duplex scan shows flow in new graft (g), which is seen
within aneurysm sac (a) and within old graft (b). There is no evidence of ongoing endoleak.
have also occurred.23,24 Residual intrasaccular flow
after nonresective aneurysm repair is analogous to
endoleaks originating from collateral sources after
endovascular abdominal aortic aneurysm repair.
These experiences provide further evidence that
rupture of incompletely excluded aneurysms after
endovascular repair can occur.
Endoleaks can be multifactorial in cause and
result from aneurysm anatomic features, endovascu-
lar graft design characteristics, or graft deployment
techniques. In this series, we evaluated aortic mor-
phologic features and their effect on endoleak inci-
dence. Aneurysms with short necks were found to
have a higher rate of endoleaks than those with
longer necks. Some of the modifications implement-
ed in the second phase of our study attempted to
address this issue.
Aneurysms with short infrarenal necks require
more exact placement of an endovascular graft’s
proximal stent and graft than those with longer
necks. If the stent and graft are deployed too low,
they may be located in aneurysmal or thrombus-
lined aorta. In these cases, progressive dilatation of
the aneurysm neck or dissolution of the thrombus
can result in stent disincorporation and an endoleak.
Moreover, there is less overlap between the graft and
the aorta to provide an effective seal. Finally, large-
diameter proximal necks may be more prone to
dilatation than smaller necks, leading to stent disin-
corporation and endoleaks.
Deployment of the proximal stent of an endovas-
cular graft in the juxtarenal versus infrarenal aorta
can potentially prevent these problems. The juxtare-
nal aorta is less susceptible to aneurysmal dilatation
and is almost never involved with thrombus. Such
deployment assures maximal overlap of the graft and
JOURNAL OF VASCULAR SURGERY
76 Wain et al. January 1998
Fig. 5. This 68-year-old man had an occluder device endoleak after treatment with an aortofemoral, femo-
rofemoral graft. A, Angiogram reveals that aneurysm sac (a) is filling with contrast material from endoleak
(b) originating in iliac occluder device. Angiogram was performed in retrograde manner through external
iliac artery (c). B, Occluder device has been packed with metallic coils, and angiogram now demonstrates
an abrupt cut-off of contrast material where endoleak had been (a). Endoleak has sealed, and contrast
material is seen only within external iliac (b) and internal iliac (c) arteries and not within aneurysm sac.
normal nondilated aortic wall. These characteristics
make the juxtarenal position a better fixation site for
the stent and assure a more hemostatic and durable
seal between the aorta and the proximal portion of
the graft.
Other changes in the second phase of our study
involved modifications to the endovascular grafts. In
contrast to the grafts inserted in phase I, the modi-
fied grafts did not require prospective determination
of graft length for each patient and did not rely on
the deployment of a second, distal stent for their
successful insertion. Instead, these grafts were long
enough so that they could be retrieved from within
the femoral arteriotomy. After customizing the
graft’s length, the distal anastomosis could then be
performed in a hand-sewn endoluminal fashion.
These changes allowed us to successfully treat
patients who had infrarenal aneurysms regardless of
their distal aneurysm neck lengths or the presence of
iliac artery aneurysmal disease. In addition, precise
preoperative graft/aneurysm length measurements,
crucial to the deployment of aortoaortic tube grafts
and aortoiliac grafts, were of much less conse-
quence. Therefore, these changes could be expected
to decrease the incidence of endoleaks that result
from inexact length measurements or misdeployed
endovascular grafts.
Although not significant, aneurysms with patent
side branches also had a higher rate of endoleaks
than those without such branches. Preoperative coil
embolization of the hypogastric artery was imple-
mented to eliminate endoleaks of hypogastric artery
origin. In the future, the potential use of preopera-
tive or intraoperative coil embolization could pre-
vent large lumbar arteries or patent inferior mesen-
teric arteries from causing endoleaks. When this will
be necessary remains to be determined because
some patent side branches thrombose and do not
cause endoleaks.
To date, there has been little consensus on how
endoleaks should be reported. The currently
described anatomic, chronologic, and physiologic
classifications group endoleaks on the basis of fea-
tures whose presence or absence is easy to ascertain.
The anatomic classification facilitates our under-
standing of the pathogenesis of endoleaks. In addi-
tion, it may help lead to improvements in endovas-
cular graft design and patient selection and therefore
decrease the endoleak rate.
The chronologic and physiologic classifications
may give us insight into the behavior of endoleaks
and how they are best treated. Current clinical and
experimental evidence suggests that aortic endoleaks
have high pressures and can cause aneurysm enlarge-
ment or rupture and should be routinely treated by
revision, surgical conversion, or other endovascular
techniques. Based on the Albany series of aneurysms
treated with retroperitoneal exclusion,22 we believe
that the collateral inflow endoleaks are also poten-
tially dangerous, although they may be associated
with lower or more variable pressures. However,
because collateral vessels often thrombose after
aneurysm repair rather than cause endoleaks, their
significance is less certain. Endoleaks that originate
from a hypogastric artery crossed by an endovascu-
lar graft can and should be prevented by preopera-
tive coil embolization. Although more difficult to
accomplish, secondary embolization of collateral
endoleaks may also be warranted. In the future, it
may be possible to choose which collateral
endoleaks require treatment and which can be safely
observed. Finally, because endoleaks can recur, life-
long surveillance must be recommended at this time
for all patients who undergo treatment with
endovascular grafts.
CONCLUSION
Endoleaks complicate a significant number of
endovascular abdominal aortic aneurysm repairs and
can lead to aneurysm rupture. The cause of
endoleaks is multifactorial and includes anatomic as
well as graft design and technique-related character-
istics. In particular, we found that aneurysm neck
lengths 2 cm or less increased the incidence of
endoleaks. The combination of juxtarenal stent
placement, preoperative hypogastric artery coil
embolization, and aortofemoral, femorofemoral
graft insertion appears to have decreased their inci-
dence. Furthermore, endoleaks can be classified
according to their anatomic, chronologic, and phys-
iologic features to facilitate their reporting. These
classifications can also improve our understanding of
the pathogenesis, clinical significance, and fate of
endoleaks and help decide how they are best treated.
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Could you comment on this theory or strategy?
Dr. Reese A. Wain. As you pointed out, the incidence
of endoleaks in the second phase of our study was consid-
erably less than that in our earlier experience. Because
patient selection did not change significantly throughout
our study, I believe that the graft design and deployment
strategies used in phase II were largely responsible for the
improved results. Although the small sample size does not
permit quantitative analysis, I believe that juxtarenal graft
placement was the single most important factor in limiting
the incidence of endoleaks. I am sure that our increasing
experience with endovascular graft procedures was a posi-
tive influence, as well.
We have not tried placing metallic coils within the
aneurysm sac in an attempt to promote thrombosis,
although the concept is intriguing. As you know, this prac-
tice was attempted in the early 1900s to treat inoperable
aneurysms when yards and yards of metallic wire were
introduced into the sac to promote thrombosis. This prac-
tice never achieved widespread appeal and was abandoned
Dr. David C. Brewster (Boston, Mass.). Obviously,
the problem of endoleaks is a very important one
because, as you and others have emphasized, this basi-
cally represents a failure of the goal of endovascular
repair, which is total exclusion of the aneurysm.
Therefore, I think your studies and observations are
clearly important. You mentioned that the incidence of
endoleaks in phase II patients was quite a bit lower, and
I wonder whether you could clarify whether you believe
that this is because of the difference in graft configura-
tion, more stringent patient selection, or perhaps simply
your increasing experience with endovascular stent-graft
placement?
Second, our own bias in an initial experience with
approximately 40 endovascular stent-graft repairs of
aortic aneurysms has been to use the adjunct of placing
coils within the aneurysm sac at the time of stent-graft
placement, hoping thereby to further promote throm-
bosis within the sac and by this additional maneuver
decrease the incidence of branch-to-branch endoleaks.
DISCUSSION
as the sole treatment for aneurysmal disease. However, as
an adjunct to endovascular grafting, this technique may be
resurrected.
Dr. Frank W. LoGerfo (Boston, Mass.). I enjoyed
your presentation and compliment you on it. We, like
many places, have been asked to participate in these trials
and are trying to get organized to do that. I have a ques-
tion related to that particular issue.
I noticed that these are straightforward aneurysms, 5
cm, long neck, and so forth. With the endovascular tech-
niques there is a stent across the renal artery orifices, there
are coils in the hypogastric, and there is a femorofemoral
graft. I am wondering how you deal with the issue of
informed consent to get patients to participate in a trial
like this when you know that surgically this is a piece of
cake. That particular aneurysm, you have to guess, is in
the 1% mortality range, no issues of sexual dysfunction
after the operation, a simple tube graft, and no concerns
about the renal arteries. How do you deal with that in
informing a patient to accept the endovascular alternative?
Dr. Wain. The majority of the patients in our series
were high-risk patients. These patients were treated only
after a cardiologist and pulmonologist independently con-
cluded that the patient could not tolerate conventional
aneurysm repair. The typical endovascular graft was not
inserted in a 50-year-old with a 5 cm aneurysm and mild
hypertension. Instead, our patients were often octogenar-
ians with 7 cm or larger aneurysms, multiply reoperated
abdomens, severely depressed ejection fractions, and
marked pulmonary dysfunction. These patients were not
candidates for open repair, and their best hope for treat-
ment was an endovascular procedure.
The good-risk patients underwent extensive counsel-
ing in the preoperative period. They were offered treat-
ment with an endovascular graft and were told explicitly
that it remains an experimental procedure. These patients
were aware of the good results that have been reported
with open repair but have nonetheless arrived at an edu-
cated decision to proceed with placement of an endovas-
cular graft.
Dr. Mark F. Fillinger (Lebanon, N.H.). I enjoyed
your presentation. I have a question about the number of
endoleaks that had no apparent outflow. As I understand
it from your presentation, the large majority of endoleaks
had no apparent outflow. I was wondering whether you
could describe your CT techniques in terms of timing and
volume of the contrast load, the beam collimation, and
interval of reconstruction. In our experience, it is very
unusual to see an endoleak without both inflow and out-
flow.
I would also like to know whether endoleaks that had
no apparent outflow were more likely to seal sponta-
neously than endoleaks that did have an outflow?
Dr. Wain. I would be interested to know how you
image your patients, because in our experience most
endoleaks have not been found to have outflow. Twelve
(71%) endoleaks had no outflow compared with only five
(29%) with outflow. Our CT scans are performed according
to a standard vascular protocol using 3 mm cuts and contrast
boluses timed to highlight the arterial anatomy. One of the
techniques we are currently evaluating is that of a delayed-
phase CT scan study, which may prove more sensitive for
detecting endoleaks.
Because of the small sample size, a comparison between
the number of endoleaks that sealed with and without out-
flow would not be meaningful.
Dr. Thomas S. Riles (New York, N.Y.). I have two
questions. One is about the classification of that one type of
leak as a low pressure leak. I’m curious to know whether
you’ve actually measured pressures in the sac to determine
that it was low pressure. From my understanding of
hydraulics, a very small artery can maintain systemic pres-
sure, especially if there is not outflow. Are you justified in
using the term “low pressure” in this context?
Second, have you classified the leaks according to the
types of grafts that you have used? I’ve been involved only
with the EVT grafts. Of the 17 successful implants we have
performed, we have had only one leak, and that occurred 2
years after implantation because of the fracture of a hook.
I’m not sure whether it’s because of the type of graft that I’m
using or selection of patients. Could you correlate the com-
plications with the different types of grafts you use?
Dr. Wain. In answering your first question, I must say
that we did not actually measure the pressures inside the
aneurysm sac. I tried to be careful in the presentation to dis-
tinguish between high-pressure (aortic) inflow endoleaks
and those endoleaks with low- or variable-pressure inflow,
which is transmitted through a collateral bed and is therefore
in some way damped. Even so, we know that collateral ves-
sels can harbor significant pressures, although I doubt that
they can achieve systemic pressure, and systolic and pulse
pressure is always less than in the aorta.
Endoleaks were discovered in three of four of our
EVT tube grafts, four of seven Parodi-type tube grafts,
four of eight aortoiliac, femorofemoral grafts, and only six
of 28 patients who were treated with aortofemoral, femo-
rofemoral grafts.
Dr. Carlos E. Donayre (Torrance, Calif.). I compli-
ment your analysis of your data. We heard earlier about the
value of intravascular ultrasound in stent deployment, and
we have also been very impressed with its use in the
deployment of stented grafts at Harbor-UCLA. Could
you comment on the use of intravascular ultrasound on
balloon-expandable covered stents? I know you have had
experience with it. Can you comment on the endoleak rate
difference between your phase I and phase II groups? Did
you use intravascular ultrasound in the phase I group or
both groups? Do you think that its use attributed to your
change in endoleak rate, especially with regard to the
proximal neck?
Dr. Wain. Thank you for raising that issue, Dr.
Donayre. We have used intravascular ultrasound in almost
all of the patients that we treated in this study, so I do not
think that the findings on ultrasound could account for
the difference in endoleak incidence. We used intravascu-
lar ultrasound to assure that the proximal stent had the
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appropriate apposition to the aortic wall and that the graft
was completely unfolded along its course. It is interesting
to note that in a study on imaging techniques for endovas-
cular grafts by Lyon et al. from our institution that
intravascular ultrasound was a poor technique for detect-
ing endoleaks, although it was more useful than fluo-
roscopy in a number of other ways, particularly in detect-
ing graft compression or narrowing.
Dr. George J. Kretschmer (Vienna, Austria). Is it
possible to distinguish primary leaks, which are observed
immediately after the procedure, and secondary leaks that
develop during late follow-up? You observed two sponta-
neously thrombosed leaks. Were these primary or sec-
ondary leaks?
Dr. Wain. Immediate or primary endoleaks are distin-
guished from delayed endoleaks by when they are discov-
ered in the postoperative period. Immediate endoleaks are
seen on the first postoperative imaging study. Delayed
endoleaks are not seen on the first postoperative study but
are visualized on a subsequent study.
Both of the endoleaks that sealed spontaneously were
primary endoleaks. One of these was a proximal endoleak
without outflow that sealed 1 month after operation, and
the other was a midgraft endoleak without outflow that
sealed within 2 months.
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